Table 4.
Probability of Relapse at 1-2 yrs in Children and Adults with Acute Leukemia Following UCBT
| Author/Study | Childhood ALL |
Childhood AML |
Combined (Childhood ALL/AML) |
Adult ALL | Adult AML | Combined (Adult ALL/AML) |
|---|---|---|---|---|---|---|
| Kurtzberg/COBLT 40 | N/A | N/A | 19% | --- | --- | --- |
| Eapen/CIBMTR 39 | N/A | N/A | 20-40% | --- | --- | --- |
| Michel/Eurocord41 | N/A | 15-25% | NA | --- | --- | --- |
| Wall/COBLT43 | N/A | N/A | 30% | --- | --- | --- |
| Rocha/EBMT42 | N/A | N/A | 38% | --- | --- | --- |
| Laughlin/multicenter28 | --- | --- | --- | N/A | N/A | 20-30% |
| Rocha/EBMT26 | --- | --- | --- | N/A | N/A | 23% |
| Ooi/University of Tokyo45 |
--- | --- | --- | N/A | 26% | NA |
| Atsuta/JCBBN44 | --- | --- | --- | 27-31% | 20-21% | N/A |
| Takahashi/University of Tokyo46 | --- | --- | --- | N/A | N/A | 16% |
UCBT, umbilical cord blood transplantation; ALL, acute lymphocytic leukemia; AML, acute myeloid leukemia; COBLT, Cord Blood Transplantation Study; CIBMTR, Center for International Blood and Marrow Transplant Research; EBMT, The European Group for Blood and Marrow Transplantation; JCBBN, Japan Cord Blood Bank Network.